Ameritas Investment Partners’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$9.36K Hold
8,358
﹤0.01% 3003
2025
Q1
$6.6K Hold
8,358
﹤0.01% 2916
2024
Q4
$13.8K Hold
8,358
﹤0.01% 2795
2024
Q3
$29.3K Hold
8,358
﹤0.01% 2468
2024
Q2
$27.4K Hold
8,358
﹤0.01% 2473
2024
Q1
$61.3K Hold
8,358
﹤0.01% 2031
2023
Q4
$31.3K Hold
8,358
﹤0.01% 2385
2023
Q3
$17.7K Buy
8,358
+2,064
+33% +$4.38K ﹤0.01% 2601
2023
Q2
$30K Hold
6,294
﹤0.01% 2335
2023
Q1
$35.9K Hold
6,294
﹤0.01% 2178
2022
Q4
$34.9K Hold
6,294
﹤0.01% 2278
2022
Q3
$141K Hold
6,294
0.01% 1261
2022
Q2
$155K Hold
6,294
0.01% 1218
2022
Q1
$244K Hold
6,294
0.01% 1062
2021
Q4
$368K Hold
6,294
0.01% 902
2021
Q3
$373K Hold
6,294
0.01% 874
2021
Q2
$546K Buy
6,294
+100
+2% +$8.68K 0.02% 770
2021
Q1
$511K Buy
6,194
+194
+3% +$16K 0.02% 778
2020
Q4
$546K Sell
6,000
-104
-2% -$9.46K 0.03% 743
2020
Q3
$244K Buy
6,104
+571
+10% +$22.8K 0.01% 936
2020
Q2
$190K Buy
5,533
+319
+6% +$11K 0.01% 1045
2020
Q1
$116K Hold
5,214
0.01% 1187
2019
Q4
$102K Buy
5,214
+776
+17% +$15.2K ﹤0.01% 1503
2019
Q3
$69K Hold
4,438
﹤0.01% 1682
2019
Q2
$90K Sell
4,438
-592
-12% -$12K ﹤0.01% 1561
2019
Q1
$88K Buy
5,030
+930
+23% +$16.3K ﹤0.01% 1555
2018
Q4
$53K Hold
4,100
﹤0.01% 1784
2018
Q3
$67K Hold
4,100
﹤0.01% 1812
2018
Q2
$46K Hold
4,100
﹤0.01% 2032
2018
Q1
$40K Buy
4,100
+754
+23% +$7.36K ﹤0.01% 2035
2017
Q4
$20K Hold
3,346
﹤0.01% 2432
2017
Q3
$12K Hold
3,346
﹤0.01% 2693
2017
Q2
$11K Buy
+3,346
New +$11K ﹤0.01% 2780